Search results
Results From The WOW.Com Content Network
Cyproterone acetate (CPA), sold alone under the brand name Androcur or with ethinylestradiol under the brand names Diane or Diane-35 among others, is an antiandrogen and progestin medication used in the treatment of androgen-dependent conditions such as acne, excessive body hair growth, early puberty, and prostate cancer, as a component of feminizing hormone therapy for transgender individuals ...
Findings were similar in another randomized controlled trial and direct head-to-head comparison of 750 mg/day flutamide and 150 mg/day oral CPA; the rates of hepatotoxicity were 15.3% (19 of 124) for flutamide and 9.5% (10 of 105) for CPA (p = 0.034) and the rates of serious hepatotoxicity were 4.8% (6 of 124) for flutamide and 3.8% (4 of 105 ...
Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. [3] Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. [4] [5]
Bubba Watson just hit the most incredible shot of the 2022 Masters so far. Deep in the pine straw on the 18th hole, it appeared Watson had little-to-no angle to go after the green. But with a ...
High-rising Peyton Watson takes the elevation of his role in stride this season. The second-year bundle of energy who comes off the bench for the Denver Nuggets has been a shot-swatting, rebound ...
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial ...
The risk of venous thromboembolism with EE/CPA-containing birth control pills is similar to that with EE and gestodene-, desogestrel-, and drospirenone-containing birth control pills and about 50 to 80% higher than with EE and levonorgestrel-containing birth control pills.
In 2014, Cipla acquired control of the company, and the company changed its name to Cipla Quality Chemical Industries Limited (CiplaQCIL). In 2016, the company was converted to a public company. Two years later, in 2018, the company listed on the Uganda Securities Exchange, offering shares to individual and institutional investors in an Initial ...